GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parmax Pharma Ltd (BOM:540359) » Definitions » E10

Parmax Pharma (BOM:540359) E10 : ₹-1.24 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Parmax Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Parmax Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹-1.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-1.24 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-03), Parmax Pharma's current stock price is ₹44.87. Parmax Pharma's E10 for the quarter that ended in Dec. 2024 was ₹-1.24. Parmax Pharma's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Parmax Pharma was 175.00. The lowest was 59.00. And the median was 75.33.


Parmax Pharma E10 Historical Data

The historical data trend for Parmax Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parmax Pharma E10 Chart

Parmax Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.50 -1.05

Parmax Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.67 -1.05 -1.06 -1.14 -1.24

Competitive Comparison of Parmax Pharma's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Parmax Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parmax Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parmax Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Parmax Pharma's Shiller PE Ratio falls into.


;
;

Parmax Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Parmax Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-1.05/158.3229*158.3229
=-1.050

Current CPI (Dec. 2024) = 158.3229.

Parmax Pharma Quarterly Data

per share eps CPI Adj_EPS
201503 0.116 97.163 0.189
201506 -0.009 99.841 -0.014
201509 -0.032 101.753 -0.050
201512 -0.016 102.901 -0.025
201603 0.063 102.518 0.097
201606 0.011 105.961 0.016
201609 0.002 105.961 0.003
201612 -0.010 105.196 -0.015
201703 0.020 105.196 0.030
201706 -0.590 107.109 -0.872
201709 -0.290 109.021 -0.421
201712 0.100 109.404 0.145
201803 1.520 109.786 2.192
201806 0.160 111.317 0.228
201809 -1.480 115.142 -2.035
201812 -0.780 115.142 -1.073
201903 2.307 118.202 3.090
201906 -0.760 120.880 -0.995
201909 1.550 123.175 1.992
201912 2.720 126.235 3.411
202003 -2.362 124.705 -2.999
202006 -2.660 127.000 -3.316
202009 1.380 130.118 1.679
202012 4.110 130.889 4.971
202103 -0.830 131.771 -0.997
202106 -1.160 134.084 -1.370
202109 3.050 135.847 3.555
202112 -1.380 138.161 -1.581
202203 -0.123 138.822 -0.140
202206 -3.520 142.347 -3.915
202209 -1.880 144.661 -2.058
202212 4.660 145.763 5.062
202303 0.460 146.865 0.496
202306 -3.150 150.280 -3.319
202309 -3.660 151.492 -3.825
202312 -4.680 152.924 -4.845
202403 -3.952 153.035 -4.089
202406 0.030 155.789 0.030
202409 -0.580 157.882 -0.582
202412 -1.050 158.323 -1.050

Add all the adjusted EPS together and divide 10 will get our e10.


Parmax Pharma  (BOM:540359) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Parmax Pharma was 175.00. The lowest was 59.00. And the median was 75.33.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Parmax Pharma E10 Related Terms

Thank you for viewing the detailed overview of Parmax Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Parmax Pharma Business Description

Traded in Other Exchanges
N/A
Address
Rajkot-Gondal National Highway No. 27, Plot No. 20, Survey No. 52, Taluka Kotda Sangani, Hadamtala, Rajkot, GJ, IND, 360 311
Parmax Pharma Ltd is a pharmaceutical company. The company manufactures and sells Tablets, Capsules, Ointments, and injectables. Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Paliperidone, Lacosamide, 2-Acetyl Benzo(B) Thiophene, Camphor Sulfonyl Chloride, 3-Methoxy Thiophene, Silodosin API, and others.

Parmax Pharma Headlines

No Headlines